Crossmark

Not BCL2 mutation but dominant mutation conversation contributed to acquired venetoclax resistance in acute myeloid leukemia

Published Online: 2021-05-01

Published Print: 2021-12

Authors

Zhang, Xiang

Qian, Jiejing

Wang, Huafeng

Wang, Yungui

Zhang, Yi

Qian, Pengxu

Lou, Yinjun

Jin, Jie

Zhu, Honghu http://orcid.org/0000-0003-2343-0436
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81800199)

Natural Science Foundation of Zhejiang Province (LY21H080003)
License Information

Text and Data Mining valid from 2021-05-01

Version of Record valid from 2021-05-01
More Information

Article History

Received: 5 January 2021

Accepted: 20 April 2021

First Online: 1 May 2021

Declarations

:

: This study was approved by the ethical review committees of the First Affiliated Hospital to Zhejiang University College of Medicine.

: Written informed consent was obtained from this patient.

: The authors declare that they have no competing interests.

Document is current